The new year enters with another bang–Elizabeth Holmes is found guilty on four investor fraud counts. Some carryover M&A with Babylon picking up their option on Higi and Vera buying into health data Castlight. Will telehealth and digital health funding continue to accelerate, or pull back for some needed reflection?
What’s next for telehealth in the (almost) aftermath–and rating the US states on policies (Maybe it’s time to look at other growth opportunities)
Short takes: 2022’s big kickoff with Babylon-Higi, Vera-Castlight buys; will funding slow down in ’22, eye-tracking telehealth for MS, vital signs tracking lightbulbs at CES 2022, and three catchups! (Did you bid a spare few billion for Watson Health?)
The Trial of Elizabeth Holmes, ch. 17: looking inside the juror decision process (Hardly ’12 Angry Men’, just jurors doing a hard job)
Breaking–The Trial of Elizabeth Holmes, ch. 16: guilty on four charges of 11 (Not the end of the legal story, but perhaps the end of the beginning)
2021 exits with a bang, between Omicron (Moronic?) and the blockbuster Oracle buy of Cerner. What will need to be resolved? Winter is the Season of Concern about the remotely located older and disabled, whose digital phones will go out when the power does, often with no backup of cell service.
Further insights on and thoughts about the Oracle acquisition of Cerner (Much to be resolved with Cerner’s healthcare clients as Oracle buys in, their way)
Does the digital telecom switchover threaten the lives of the most remote old and disabled? (UK, updated) (Winter brings the bad combination of distance, isolation, bad weather, and technology that doesn’t compensate. And it’s the same in the US and EU.)
(Breaking) Sold! Cerner to Oracle for $28.3 billion. And is Epic next? (A curious press release, and Judy Feinberg, what now?)
The Theranos trial winds up after 14 weeks with prosecution and defense summaries–the jury will deliberate starting Monday. Oracle may be buying Cerner in a $30 billion deal. And in payer news, UHG has to delay Change closing, Centene’s CEO is retired in big shakeup, and Amazon finally brings healthcare under one leader.
News roundup: UnitedHealth Group pushes off Change closing again, Amazon’s new healthcare head, Centene’s shakeup of CEO, board, holdings
Theranos, The Trial of Elizabeth Holmes closes, ch. 15: she believed! in the technology!
Oracle in negotiations to buy Cerner for $30B
Theranos, The Trial of Elizabeth Holmes closes, ch. 14: was it fraud over business failure–or building a company, not a criminal enterprise?
Holmes, and her defense, rests, but not after Blaming Balwani and not remembering a great deal, including all those Theranos investors. As activity winds down at year’s end, we turn to the UK scene: government funding of social care tech, investigating design bias in medical device use, and Vinehealth’s £4.1M in its seed round. In the US, one specialty EHR buys another specialty EHR software developer in further consolidation.
Short takes: £150 million for UK social care tech out of £1 billion, bias by design in medical device use investigated, Netsmart buys Remarkable Health, Vinehealth seed rounds £4.1 million (Mostly UK updates here, but why no $ mentioned by Netsmart?)
Theranos, The Trial of Elizabeth Holmes, ch. 13: a crescendo of ‘I don’t knows’ and ‘I don’t remembers’…and the defense rests! (updated) (The health tech Trial of the Century begins to wind up in time for Christmas)
Holmes testifies about her Boss Lady Life At Theranos, staying on strategy with deflection, blaming others, and a soupçon of diminished capacity. Athenahealth sold to new investors, VA reorganizes to restart their Cerner implementation, CVS and Microsoft do another deal. A POV on patient engagement. And disappointingly, Owlet’s baby monitor sock runs afoul of the FDA.
Owlet sock pulled from US distribution after FDA warning letter (Owww! A setback for a high flyer)
News and deal roundup: Best Buy’s $400M for Current, VA’s Cerner restart 2022, CVS-Microsoft product deal, and Athenahealth (finally) sold for $17B (Deals may be winding down, but they’re still rich)
Theranos, The Trial of Elizabeth Holmes, ch. 12: all bucks stop with the CEO (updated) (It’s beginning to feel like Twinkie Defense Variations)
Perspectives: How enhanced digital communications can improve patient engagement (Avaya’s insight on designing your communications)
Theranos, The Trial of Elizabeth Holmes, ch. 11: Holmes’ widening gyre of diffusion of blame–and abuse (A lurid Svengali story that woke up the jury)
Theranos, The Trial of Elizabeth Holmes, ch. 10: Holmes testifies about the salad days of Theranos, setting up cognitive dissonance (When in doubt, deflect from the forgery with idealism)
Have a job to fill? Seeking a position? Free listings available to match our Readers with the right opportunities. Email Editor Donna.
Read Telehealth and Telecare Aware: https://telecareaware.com/ @telecareaware
We thank our present and past advertisers and supporters: Legrand/Tynetec, Eldercare, UK Telehealthcare, NYeC, PCHAlliance, ATA, The King’s Fund, DHACA, HIMSS, Health 2.0 NYC, MedStartr, Parks Associates, and HealthIMPACT.
Reach international leaders in health tech by advertising your company or event/conference in TTA–contact Donna for more information on how we help and who we reach. See our advert information here.
Telehealth & Telecare Aware: covering the news on latest developments in telecare, telehealth, telemedicine, and health tech, worldwide–thoughtfully and from the view of fellow professionals
Thanks for asking for update emails. Please tell your colleagues about this news service and, if you have relevant information to share with the rest of the world, please let me know.
Donna Cusano, Editor In Chief
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –